Dr. med. Ellen Harrer



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection (2024) Kießling M, Cole JJ, Kübel S, Klein P, Korn K, Henry AR, Laboune F, et al. Journal article Increased human herpesvirus-8 neutralizing response during remission from Kaposi’s sarcoma (2024) Byren H, Holzer A, Müller A, Korn K, Backovic M, Harrer E, Bergmann S, et al. Journal article Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller (2023) El Kenz B, Schmidt K, Ogungbemi-Alt VK, Bergmann S, Steininger P, Korn K, Spriewald B, et al. Journal article Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy (2023) Fischhaber N, Schmiedeberg M, Kübel S, Harrer E, Harrer T, Nganou-Makamdop K Journal article Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine (2023) Schmidt K, Harrer E, Schönau V, Simon D, Kleyer A, Steininger P, Korn K, et al. Journal article Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection (2022) Schmidt KG, Harrer E, Tascilar K, Kuebel S, El Kenz B, Simon D, Schett G, et al. Journal article, Original article SARS-CoV-2-seronegative subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses (2021) Schmidt K, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, et al. Conference contribution SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses (2021) Schmidt K, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, et al. Journal article SARS-CoV-2-seronegative HIV-1-infected subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses (2021) Schmidt K, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, et al. Conference contribution Human T cells expressing two additional receptors (TETARs) specific for HIV-1 recognize both epitopes (2011) Hofmann C, Hoefflin S, Hueckelhoven A, Bergmann S, Harrer E, Schuler G, Dörrie J, et al. Journal article